A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets
Clinical trial NCT01322867 · COMPLETED
Trial details
- NCT number
- NCT01322867
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.